Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio

Critical Jh Syngeneic Tumor Model Host Now Available on a B6 Background RENSSELAER, N.Y., Jan. 18, 2021 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno-oncology portfolio. Immuno-oncology is a leading research priority because it uses the body’s own immune system to effectively […]

Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio

Critical Jh Syngeneic Tumor Model Host Now Available on a B6 Background RENSSELAER, N.Y., Jan. 18, 2021 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno-oncology portfolio. Immuno-oncology is a leading research priority because it uses the body’s own immune system to effectively […]